Trench fever medical therapy

Jump to navigation Jump to search

Trench fever Microchapters

Home

Patient Information

Overview

Historical Perspective

Pathophysiology

Causes

Differentiating Trench fever from other Diseases

Epidemiology and Demographics

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Other Diagnostic Studies

Treatment

Medical Therapy

Primary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Trench fever medical therapy On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Trench fever medical therapy

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Trench fever medical therapy

CDC on Trench fever medical therapy

Trench fever medical therapy in the news

Blogs on Trench fever medical therapy

Directions to Hospitals Treating Trench fever

Risk calculators and risk factors for Trench fever medical therapy

Please help WikiDoc by adding more content here. It's easy! Click here to learn about editing.

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Tetracycline-group antibiotics (doxycycline, tetracycline) are commonly used. Chloramphenicol is an alternative medication recommended under circumstances that render tetracycline derivates usage undesirable (such as severe liver malfunction, kidney deficiency, in children under nine years and pregnant women). The drug is administered for seven to ten days.

The treatment for bacillary angiomatosis is erythromycin given for three to four months.[1]

References

  1. Beghari S, Rolain J-M, Grau GE; et al. (2006). "Antiangiogenic effect of erythromycin: an in vitro model of Bartonella quintana infection". J Infect Dis. 193 (3): 380&ndash, 6.


Template:WikiDoc Sources